Genentech partners with OneOncology on personalized cancer research in U.S.

 

• Roche (OTCQX:RHHBY) unit Genentech and OneOncology unveiled a collaboration for various clinical trials, scientific research and real-world data studies to advance personalized cancer care at community oncology centers across the U.S. and announced the first clinical trial available through OneR, the OneOncology Research Network.
• The partnership's goals are to enhance clinical assessment of comprehensive genomic profiling (CGP), increase access to clinical trials and improve therapeutic options for patients.
• OneOncology and Genentech will also establish a joint committee that will design studies to evaluate the impact of personalized healthcare on outcomes for patients, the healthcare system and society.
• The partnership will explore new methods for enabling just-in-time clinical research site start-up and patient identification across OneR.
• https://seekingalpha.com/news/3638611-genentech-partners-oneoncology-to-bring-personalized-cancer-research-in-u-s